切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Ribosomal s6 kinases (RSK) - YES - Na /K /Cl- Symporters (NKCCs) - Inward Rectifier Potassium (Kir) Channels

10 件产品

每页
清除全部
  1. SU6656
    B5839 SU6656
    Target: Src|Lyn|YES|Fyn
    Summary: Src 酪氨酸激酶抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. Furosemide
    A8435 Furosemide
    中文名: 呋塞米
    Target: Na /K /Cl- Symporters (NKCCs)|GABAA Receptors
    Summary: GABAA受体拮抗剂
      ≥14.9 mg/mL
      insoluble in H2O
  8. FMK
    A3420 FMK
    Target: Ribosomal s6 kinases (RSK)
    Summary: RSK抑制剂
      ≥17.1 mg/mL
      insoluble in H2O
  9. TAK-901
    A4124 TAK-901
    Target: Aurora Kinases|FLT3|Src|JAK|LRRK2|Hck|FGR|YES|Fyn|ARG
    Summary: Aurora A/B抑制剂
      ≥25.25 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页